nefazodone has been researched along with Hyperlipidemias in 2 studies
nefazodone: may be useful as an opiate adjunct
Hyperlipidemias: Conditions with excess LIPIDS in the blood.
Excerpt | Relevance | Reference |
---|---|---|
"Simvastatin is a hydroxymethyl glutaryl coenzyme A reductase inhibitor commonly used to treat patients with hyperlipidemia." | 5.32 | Rhabdomyolysis associated with simvastatin-nefazodone therapy. ( Monaghan, MS; Skrabal, MZ; Stading, JA, 2003) |
"Simvastatin is a hydroxymethyl glutaryl coenzyme A reductase inhibitor commonly used to treat patients with hyperlipidemia." | 1.32 | Rhabdomyolysis associated with simvastatin-nefazodone therapy. ( Monaghan, MS; Skrabal, MZ; Stading, JA, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Thompson, M | 1 |
Samuels, S | 1 |
Skrabal, MZ | 1 |
Stading, JA | 1 |
Monaghan, MS | 1 |
2 other studies available for nefazodone and Hyperlipidemias
Article | Year |
---|---|
Rhabdomyolysis with simvastatin and nefazodone.
Topics: Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Humans; Hype | 2002 |
Rhabdomyolysis associated with simvastatin-nefazodone therapy.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Humans; Hydroxymet | 2003 |